Fitbit and coaching may help HIV patients cut back on heavy drinking
NCT ID NCT05505942
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a home-based physical activity program, using a Fitbit and coaching sessions, can help people with HIV who drink heavily increase their daily steps and reduce their alcohol intake. The trial involves 222 participants in the U.S. who are low-active and drink above healthy limits. Half receive coaching plus a Fitbit, the other half just a Fitbit, and progress is tracked at 3 and 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lifestyle physical activity sessions and a Fitbit
What this could lead to
If it works, this could offer a simple, home-based way to help people with HIV who drink heavily become more active and reduce their drinking.
What could go wrong
This is a small, early-stage trial with only 222 participants, and the results may not apply to everyone. The intervention is behavioral, so success depends on individual motivation and adherence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston University, Department of Medicine, remote research
Boston, Massachusetts, 02118, United States